The Dr. Stephen A. Harrison Patient Advocacy Fellowship Program is a pioneering initiative designed to elevate the role of patient advocates in MASH (Metabolic Dysfunction-Associated Steatohepatitis) and steatotic liver disease (SLD) research, drug and diagnostic development, and policy discussions. This annual fellowship empowers up to 20 patient advocates by providing financial support, education, and access to key scientific and policy forums where they can contribute meaningfully to shaping the future of liver disease care.

Through a guided learning experience and engagement with leading researchers, patient advocates, policymakers, and industry stakeholders, fellows will develop the knowledge, leadership skills, and networks necessary... read more →

Dr. Stephen A. Harrison was a visionary in MASH research, clinical trials, and patient advocacy, leaving an enduring impact on the field. His commitment to patient-centered drug development shaped how clinical research integrates patient perspectives.

Throughout his career, Dr. Harrison:

• Played a pivotal role in advancing MASH clinical trials and therapeutic development.
• Championed patient engagement in research and regulatory discussions.
• Collaborated closely with leading stakeholders, including industry, policymakers, and advocacy groups, to push forward solutions that directly benefit patients.

This fellowship was established to honor his extraordinary contributions by equipping the next generation of patient advocates with the... read more →

The fellowship program is structured around four core objectives:

1. Support Up to 20 Patient Advocates Annually
   • Provide funding for travel, lodging, conference registrations, and stipend to facilitate participation in leading scientific and policy forums.
2. Build Capacity through Education
   • Offer specialized training on clinical trials literacy, drug development, and regulatory processes.
   • Equip advocates with tools to engage with researchers, industry leaders, and policymakers.
3. Foster a Rigorous, Competitive Selection Process
   • Establish a Selection Committee composed of experienced patient advocates and representatives from key stakeholder groups to oversee the fellow selection process.
   ... read more →

Fellows accepted into the program will receive:

• Financial Support – Travel, lodging, and conference registrations.
• Expert-Led Training – Workshops, mentorship, and resources to enhance advocacy skills.
• Exclusive Networking Opportunities – Access to KOLs, policymakers, and research leaders in hepatology.
• Participation in Key Conferences – Fellows will attend leading scientific and policy meetings where they can directly contribute to discussions on MASH and steatotic liver disease clinical research.
• Recognition & Leadership Development – A platform to grow as influential patient advocates, shaping future treatments and policies.